Oncternal Therapeutics (ONCT) PT Raised to $30 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts ONCT Hot Sheet
Price: $0.53 --0%
Rating Summary:
3 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 4 | New: 3
Rating Summary:
3 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 4 | New: 3
Join SI Premium – FREE
H.C. Wainwright analyst Raghuram Selvaraju raised the price target on Oncternal Therapeutics (NASDAQ: ONCT) to $30.00 (from $2.00) while maintaining a Buy rating.
You May Also Be Interested In
- Nomura/Instinet Upgrades Malayan Banking Bhd (MAY:MK) to Buy
- Ningbo Tuopu Group Co Ltd (601689:CH) PT Lowered to RMB55 at Goldman Sachs
- Muyuan Foods Co Ltd (002714:CH) PT Lowered to RMB51.36 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
